<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000413943"><TermName>CellCept</TermName><TermPronunciation>(SEL-sept)</TermPronunciation><TermDefinition><DefinitionText>A drug used to prevent graft-versus-host disease (GVHD) after organ transplants. It is also being studied in the prevention of GVHD after stem cell transplants for cancer, and in the treatment of some autoimmune disorders. CellCept is a type of immunosuppressive agent. Also called mycophenolate mofetil.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713512" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;CellCept&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713511" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;CellCept&quot;" language="es" id="_4"/><SpanishTermName>CellCept</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar la enfermedad de injerto contra huésped (EICH) después de trasplantes de órganos. Asimismo, está en estudio para la prevención de la EICH después de trasplantes de células madre para tratar el cáncer y para el tratamiento de algunos trastornos autoinmunitarios. CellCept es un tipo de inmunosupresor. También se llama micofenolato mofetil.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-10-10</DateFirstPublished><DateLastModified>2007-10-08</DateLastModified></GlossaryTerm>
